Zhang, J., Shi, S., Zhang, Y., Luo, J., Xiao, Y., Meng, L., & Yang, X. (2017). alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis. Cochrane Database Syst Rev.

Zhang, Jian, Shengliang Shi, Yueling Zhang, Jiefeng Luo, Yousheng Xiao, Lian Meng, und Xiaobo Yang. "Alemtuzumab Versus Interferon Beta 1a for Relapsing‐remitting Multiple Sclerosis." Cochrane Database Syst Rev 2017.

Zhang, Jian, et al. "Alemtuzumab Versus Interferon Beta 1a for Relapsing‐remitting Multiple Sclerosis." Cochrane Database Syst Rev 2017.